Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.

Jhaveri, K L; Wang, X V; Makker, V; Luoh, S-W; Mitchell, E P; Zwiebel, J A; Sharon, E; Gray, R J; Li, S; McShane, L M; Rubinstein, L V; Patton, D; Williams, P M; Hamilton, S R; Conley, B A; Arteaga, C L; Harris, L N; O'Dwyer, P J; Chen, A P; Flaherty, K T.

Ann Oncol ; 30(11): 1821-1830, 2019 11 01.

Artigo em Inglês | MEDLINE | ID: mdl-31504139

2.

Corrigendum to 'Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q': [Annals of Oncology 30 (2019) 1821-1830].

Jhaveri, K L; Wang, X V; Makker, V; Luoh, S-W; Mitchell, E P; Zwiebel, J A; Sharon, E; Gray, R J; Li, S; McShane, L M; Rubinstein, L V; Patton, D; Williams, P M; Hamilton, S R; Conley, B A; Arteaga, C L; Harris, L N; O'Dwyer, P J; Chen, A P; Flaherty, K T.

Ann Oncol ; 32(8): 1068, 2021 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-34099371

3.

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.

Mansfield, A S; Wei, Z; Mehra, R; Shaw, A T; Lieu, C H; Forde, P M; Drilon, A E; Mitchell, E P; Wright, J J; Takebe, N; Sharon, E; Hovelson, D; Tomlins, S; Zeng, J; Poorman, K; Malik, N; Gray, R J; Li, S; McShane, L M; Rubinstein, L V; Patton, D; Williams, P M; Hamilton, S R; Conley, B A; Arteaga, C L; Harris, L N; O'Dwyer, P J; Chen, A P; Flaherty, K T.

NPJ Precis Oncol ; 6(1): 13, 2022 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-35233056

4.

Neural computing in cancer drug development: predicting mechanism of action.

Weinstein, J N; Kohn, K W; Grever, M R; Viswanadhan, V N; Rubinstein, L V; Monks, A P; Scudiero, D A; Welch, L; Koutsoukos, A D; Chiausa, A J.

Science ; 258(5081): 447-51, 1992 Oct 16.

Artigo em Inglês | MEDLINE | ID: mdl-1411538

5.

An information-intensive approach to the molecular pharmacology of cancer.

Weinstein, J N; Myers, T G; O'Connor, P M; Friend, S H; Fornace, A J; Kohn, K W; Fojo, T; Bates, S E; Rubinstein, L V; Anderson, N L; Buolamwini, J K; van Osdol, W W; Monks, A P; Scudiero, D A; Sausville, E A; Zaharevitz, D W; Bunow, B; Viswanadhan, V N; Johnson, G S; Wittes, R E; Paull, K D.

Science ; 275(5298): 343-9, 1997 Jan 17.

Artigo em Inglês | MEDLINE | ID: mdl-8994024

6.

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.

Rubinstein, L V; Shoemaker, R H; Paull, K D; Simon, R M; Tosini, S; Skehan, P; Scudiero, D A; Monks, A; Boyd, M R.

J Natl Cancer Inst ; 82(13): 1113-8, 1990 Jul 04.

Artigo em Inglês | MEDLINE | ID: mdl-2359137

7.

Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.

Sznol, M; Clark, J W; Smith, J W; Steis, R G; Urba, W J; Rubinstein, L V; VanderMolen, L A; Janik, J; Sharfman, W H; Fenton, R G.

J Natl Cancer Inst ; 84(12): 929-37, 1992 Jun 17.

Artigo em Inglês | MEDLINE | ID: mdl-1629914

8.

Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.

Plowman, J; Waud, W R; Koutsoukos, A D; Rubinstein, L V; Moore, T D; Grever, M R.

Cancer Res ; 54(14): 3793-9, 1994 Jul 15.

Artigo em Inglês | MEDLINE | ID: mdl-8033099

9.

Glucose metabolism and the percentage of glucose derived from alanine: response to exogenous glucose infusion in tumor-bearing and non-tumor-bearing rats.

Arbeit, J M; Burt, M E; Rubinstein, L V; Gorschboth, C M; Brennan, M F.

Cancer Res ; 42(12): 4936-42, 1982 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-7139597

10.

Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.

Koo, H M; Monks, A; Mikheev, A; Rubinstein, L V; Gray-Goodrich, M; McWilliams, M J; Alvord, W G; Oie, H K; Gazdar, A F; Paull, K D; Zarbl, H; Vande Woude, G F.

Cancer Res ; 56(22): 5211-6, 1996 Nov 15.

Artigo em Inglês | MEDLINE | ID: mdl-8912859

11.

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.

Wu, L; Smythe, A M; Stinson, S F; Mullendore, L A; Monks, A; Scudiero, D A; Paull, K D; Koutsoukos, A D; Rubinstein, L V; Boyd, M R.

Cancer Res ; 52(11): 3029-34, 1992 Jun 01.

Artigo em Inglês | MEDLINE | ID: mdl-1350507

12.

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Feld, R; Rubinstein, L V; Weisenberger, T H.

J Clin Oncol ; 2(12): 1352-8, 1984 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-6512581

13.

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Ginsberg, R J; Rubinstein, L V.

Ann Thorac Surg ; 60(3): 615-22; discussion 622-3, 1995 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-7677489

14.

Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate.

Foster, B J; Grotzinger, K R; McKoy, W M; Rubinstein, L V; Hamilton, T C.

Cancer Chemother Pharmacol ; 22(2): 147-52, 1988.

Artigo em Inglês | MEDLINE | ID: mdl-3409446

15.

Therapeutic studies.

Rubinstein, L V.

Hematol Oncol Clin North Am ; 14(4): 849-76, ix, 2000 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-10949777

16.

Markov models for covariate dependence of binary sequences.

Muenz, L R; Rubinstein, L V.

Biometrics ; 41(1): 91-101, 1985 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-4005390

17.

Monitoring rules for stopping accrual in comparative survival studies.

Rubinstein, L V; Gail, M H.

Control Clin Trials ; 3(4): 325-43, 1982 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-7160190

18.

MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study.

Hricak, H; Rubinstein, L V; Gherman, G M; Karstaedt, N.

Radiology ; 179(3): 829-32, 1991 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-2028000

19.

A comparison of two phase I trial designs.

Korn, E L; Midthune, D; Chen, T T; Rubinstein, L V; Christian, M C; Simon, R M.

Stat Med ; 13(18): 1799-806, 1994 Sep 30.

Artigo em Inglês | MEDLINE | ID: mdl-7997713

20.

Vaginal clear cell adenocarcinoma in the United States.

Trimble, E L; Rubinstein, L V; Menck, H R; Hankey, B F; Kosary, C; Giusti, R M.

Gynecol Oncol ; 61(1): 113-5, 1996 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-8626097

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: